Drupal.behaviors.print = function(context) {window.print();window.close();}>
FDA Official Says IND Hurdles for Oligos Similar to Other Drugs, Calls for Greater Awareness of Tech
April 19, 2012
FDA Official Says IND Hurdles for Oligos Similar to Other Drugs, Calls for Greater Awareness of Tech
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
UniQure, Collaborators Secure $3.2M Eurostar Grant for Huntington’s Disease Effort
May 23, 2013 / Gene Silencing News
Tools & Techniques: TALENs for miRNA Manipulation; CLASH for miRNA-Target Analysis; and More
May 23, 2013 / Gene Silencing News
IP Update: Recent Patents, Patent Applications Awarded to Alnylam, Novartis, Tekmira, and More
May 23, 2013 / Gene Silencing News
IP Update: Recent Patents, Patent Applications Awarded to Santaris, Nitto Denko, BASF, and More
May 16, 2013 / Gene Silencing News
Tools & Techniques: siRNA Delivery to Endothelia; miRNA Analysis in Non-Model Animals; and More
May 9, 2013 / Gene Silencing News